Combination of Lipitor and Celebrex Inhibits Prostate Cancer VCaP Cells In Vitro and In Vivo

BACKGROUND/AIM: Lipitor is a cholesterol-lowering drug and Celebrex is a cyclooxygenase 2 inhibitor. We investigated the effects of Lipitor and Celebrex on human prostate cancer VCaP cells cultured in vitro and grown as orthotopic xenograft tumors in SCID mice. MATERIALS AND METHODS: Apoptosis was m...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Anticancer Res
Autors principals: Huang, Huarong, Cui, Xiao-Xing, Chen, Shaohua, Goodin, Susan, Liu, Yue, He, Yan, Li, Dongli, Wang, Hong, Van Doren, Jeremiah, DiPaola, Robert S, Conney, Allan H., Zheng, Xi
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5249253/
https://ncbi.nlm.nih.gov/pubmed/24982340
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars